Food and Drug Administration
Transmissible Spongiform Encephalopathies Advisory Committee
October 25, 2001
Slides
Topic I: FDA Draft Guidance "Revised Preventive Measures to Reduce the Possible Risk of Transmission of CJD and vCJD by Blood and Blood Products" Dorothy Scott, MD, FDA ppt htm
Update: DHHS Meeting held on September 24, 2001, Stephen D Nightingale, MD, Office of Public Health and Science pdf
Update: Anticipated implementation of New Donor Deferral Policies
Celso Bianco, MD, America's Blood Centers pdf
Jacquelyn Fredrick, American Red Cross pdf
Robert Jones, MD, New York Blood Center pdf
G. Michael Fitzpatrick, PhD, Col, MS, Armed Service Blood Program, DoD ppt htm
Topic 2. Discussion of Amino Acid Sourcing and Production, and the Theoretical Risk of Transmission of the BSE Agent Through Their Use in Biopharmaceutical Products, Gerald Feldman, PhD, FDA ppt htm
Amino Acid Products, Gerard Richet, Degussa-Rexim ppt htm
Open Public Hearing
American Association of Blood Banks, Karen Shoos Lipton, JD pdf